re: Ann: Neuren places $3m of rights issue sh... CHawkey, the game is in play. no worry about too hard too soon. Its all underway.
No backing off now. Two drugs in phase 2 trials.
No competitors, No toxicity,
NNZ-2566 has the easiest Phase 3 . In this case Phase 2 is the big deal. pass that and we are heading for BLOCKBUSTER status.
And we have 10 uses for the drug. That is. One drug X Ten Blockbusters.
Have a good read about this. Injectile $2 Billion. Oral $ 2 Billion.
Eight more uses.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.72 |
Change
-0.120(1.53%) |
Mkt cap ! $875.6M | |||
| Open | High | Low | Value | Volume |
| $7.80 | $7.87 | $7.61 | $1.334M | 173.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 685 | $7.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.75 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| AEF (ASX) Chart |